DNA-topoisomerase I and II: biologic features and their role in drug resistance.
作者信息
Russo D, Marie J P, Delmer A, Zhou D, Suberville A M, Baccarani M, Zittoun R
出版信息
Haematologica. 1993 Jul-Aug;78(4):201-7.
PMID:8294050
Abstract
摘要
相似文献
1
DNA-topoisomerase I and II: biologic features and their role in drug resistance.DNA拓扑异构酶I和II：生物学特性及其在耐药性中的作用。
Haematologica. 1993 Jul-Aug;78(4):201-7.
2
Mechanisms of resistance to drugs that inhibit DNA topoisomerases.对抑制DNA拓扑异构酶药物的耐药机制。
Semin Cancer Biol. 1991 Aug;2(4):235-44.
3
[Recent progress in the study of the mechanism of resistance to DNA topoisomerase inhibitors].[DNA拓扑异构酶抑制剂耐药机制研究的最新进展]
Gan To Kagaku Ryoho. 1994 Jun;21(7):952-61.
4
[Inhibitors of DNA topoisomerases].[DNA拓扑异构酶抑制剂]
Gan To Kagaku Ryoho. 1997 Sep;24(11):1526-35.
5
Topoisomerase-targeting antitumor drugs: mechanisms of cytotoxicity and resistance.靶向拓扑异构酶的抗肿瘤药物：细胞毒性和耐药机制
Important Adv Oncol. 1992:79-89.
6
7
Drug resistance to DNA topoisomerase I and II inhibitors in human leukemia, lymphoma, and multiple myeloma.
Semin Hematol. 1997 Oct;34(4 Suppl 5):48-62.
8
DNA topoisomerases and topoisomerase inhibitors.
Pathol Biol (Paris). 1994 Apr;42(4):346-52.
9
Cytotoxic mechanism of XK469: resistance of topoisomerase IIbeta knockout cells and inhibition of topoisomerase I.XK469的细胞毒性机制：拓扑异构酶IIβ基因敲除细胞的抗性及对拓扑异构酶I的抑制作用
Biochem Biophys Res Commun. 2001 Feb 2;280(4):1155-60. doi: 10.1006/bbrc.2001.4249.
10
DNA topoisomerase dysfunction: a new goal for antitumor chemotherapy.
Bioessays. 1990 Apr;12(4):167-72. doi: 10.1002/bies.950120405.
Zotero 插件